Berta Casar

7PUBLICATIONS
30CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 11, 2025
Identification and Characterization of ERK2 Dimerization Inhibitors by Integrated In Silico and In Vitro Screening.

Carmen Ortiz-González, Berta Casar, Rafael Gozalbes

|Oct 17, 2025
ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA Methylation.

Óscar Monteagudo-García, Paz Nombela, Ángel Carlos Román

|Sep 28, 2024
Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma.

Fani Karagianni, Christina Piperi, Sara Valero-Diaz

|Sep 12, 2024
ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility.

Dalia de la Fuente-Vivas, Vincenzo Cappitelli, Rocío García-Gómez

|Feb 15, 2023
Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species.

Ana Martín-Vega, Laura Ruiz-Peinado, Rocío García-Gómez

Pageof 2